Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelley L Deeks

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
The Journal of Infectious Diseases|January 5, 2021
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody DeclineShelly Bolotin, Vanessa Tran, Selma Osman, et al.
Journal of Medical Microbiology|October 6, 2012
Genetic and antigenic characterization of invasive endemic serogroup B Neisseria meningitidis from Ontario, Canada, in 2001-2010Frances B Jamieson, Prasad Rawte, Shelley L Deeks, et al.
Plos One|February 11, 2021
Herpes zoster in older adults in Ontario, 2002-2016: Investigating incidence and exploring equitySarah A Buchan, Nick Daneman, Jun Wang, et al.
Human Vaccines & Immunotherapeutics|February 25, 2016
An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccinationKumanan Wilson, Katherine M Atkinson, Jacqueline Westeinde, et al.
Plos One|July 18, 2015
Correlation of Real Time PCR Cycle Threshold Cut-Off with Bordetella pertussis Clinical SeverityShelly Bolotin, Shelley L Deeks, Alex Marchand-Austin, et al.
BMC Infectious Diseases|August 30, 2012
Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010Vica Dang, Frances B Jamieson, Sarah Wilson, et al.
Open Forum Infectious Diseases|June 13, 2024
Invasive Pneumococcal Disease Epidemiology and Serotype Replacement After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Ontario, Canada, 2007-2022Ramandip Grewal, Kelty Hillier, Shelley L Deeks, et al.
Plos One|May 12, 2016
Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect EffectsSarah E Wilson, Laura C Rosella, Jun Wang, et al.
BMC Infectious Diseases|August 19, 2015
Global travel patterns and risk of measles in Ontario and Quebec, Canada: 2007-2011Sarah E Wilson, Kamran Khan, Vladimir Gilca, et al.
Vaccine|February 6, 2018
Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature reviewFiona M Guerra, Natasha S Crowcroft, Lindsay Friedman, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
The Journal of Infectious Diseases|January 5, 2021
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody DeclineShelly Bolotin, Vanessa Tran, Selma Osman, et al.
Journal of Medical Microbiology|October 6, 2012
Genetic and antigenic characterization of invasive endemic serogroup B Neisseria meningitidis from Ontario, Canada, in 2001-2010Frances B Jamieson, Prasad Rawte, Shelley L Deeks, et al.
Plos One|February 11, 2021
Herpes zoster in older adults in Ontario, 2002-2016: Investigating incidence and exploring equitySarah A Buchan, Nick Daneman, Jun Wang, et al.
Human Vaccines & Immunotherapeutics|February 25, 2016
An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccinationKumanan Wilson, Katherine M Atkinson, Jacqueline Westeinde, et al.
Plos One|July 18, 2015
Correlation of Real Time PCR Cycle Threshold Cut-Off with Bordetella pertussis Clinical SeverityShelly Bolotin, Shelley L Deeks, Alex Marchand-Austin, et al.
BMC Infectious Diseases|August 30, 2012
Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010Vica Dang, Frances B Jamieson, Sarah Wilson, et al.
Open Forum Infectious Diseases|June 13, 2024
Invasive Pneumococcal Disease Epidemiology and Serotype Replacement After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Ontario, Canada, 2007-2022Ramandip Grewal, Kelty Hillier, Shelley L Deeks, et al.
Plos One|May 12, 2016
Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect EffectsSarah E Wilson, Laura C Rosella, Jun Wang, et al.
BMC Infectious Diseases|August 19, 2015
Global travel patterns and risk of measles in Ontario and Quebec, Canada: 2007-2011Sarah E Wilson, Kamran Khan, Vladimir Gilca, et al.
Vaccine|February 6, 2018
Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature reviewFiona M Guerra, Natasha S Crowcroft, Lindsay Friedman, et al.
Pageof 13